Treatment of neuroleptic-induced tardive dyskinesia with levetiracetam - A case series

被引：15
|
作者：
Bona, JR [1 ]
机构：
[1] DeKalb Community Serv Board, Atlanta, GA USA
[2] Emory Univ, Dept Psychiat & Behav Sci, Atlanta, GA USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2006年 / 26卷 / 02期
关键词：
D O I：
10.1097/01.jcp.0000203823.60603.80
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：215 / 216
页数：2
相关论文
共 50 条
  • [21] Association of the HSPG2 Gene with Neuroleptic-Induced Tardive Dyskinesia
    Syu, Aoi
    Ishiguro, Hiroki
    Inada, Toshiya
    Horiuchi, Yasue
    Tanaka, Syunsuke
    Ishikawa, Maya
    Arai, Makoto
    Itokawa, Masanari
    Niizato, Kazuhiro
    Iritani, Shuji
    Ozaki, Norio
    Takahashi, Makoto
    Kakita, Akiyoshi
    Takahashi, Hitoshi
    Nawa, Hiroyuki
    Keino-Masu, Kazuko
    Arikawa-Hirasawa, Eri
    Arinami, Tadao
    NEUROPSYCHOPHARMACOLOGY, 2010, 35 (05) : 1155 - 1164
  • [22] Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia
    Alabed, Samer
    Latifeh, Youssef
    Mohammad, Husam Aldeen
    Rifai, Abdullah
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (04):
  • [23] DOPAMINE, GABA, CHOLECYSTOKININ AND OPIOIDS IN NEUROLEPTIC-INDUCED TARDIVE-DYSKINESIA
    EBADI, M
    HAMA, Y
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1988, 12 (3-4): : 179 - 187
  • [24] DPP6 as a candidate gene for neuroleptic-induced tardive dyskinesia
    S Tanaka
    A Syu
    H Ishiguro
    T Inada
    Y Horiuchi
    M Ishikawa
    M Koga
    E Noguchi
    N Ozaki
    T Someya
    A Kakita
    H Takahashi
    H Nawa
    T Arinami
    The Pharmacogenomics Journal, 2013, 13 : 27 - 34
  • [25] DPP6 as a candidate gene for neuroleptic-induced tardive dyskinesia
    Tanaka, S.
    Syu, A.
    Ishiguro, H.
    Inada, T.
    Horiuchi, Y.
    Ishikawa, M.
    Koga, M.
    Noguchi, E.
    Ozaki, N.
    Someya, T.
    Kakita, A.
    Takahashi, H.
    Nawa, H.
    Arinami, T.
    PHARMACOGENOMICS JOURNAL, 2013, 13 (01): : 27 - 34
  • [26] Levetiracetam as a treatment for tardive dyskinesia: A case report
    McGavin, CL
    John, V
    Musser, WS
    NEUROLOGY, 2003, 61 (03) : 419 - 420
  • [27] Association of the HSPG2 Gene with Neuroleptic-Induced Tardive Dyskinesia
    Aoi Syu
    Hiroki Ishiguro
    Toshiya Inada
    Yasue Horiuchi
    Syunsuke Tanaka
    Maya Ishikawa
    Makoto Arai
    Masanari Itokawa
    Kazuhiro Niizato
    Shuji Iritani
    Norio Ozaki
    Makoto Takahashi
    Akiyoshi Kakita
    Hitoshi Takahashi
    Hiroyuki Nawa
    Kazuko Keino-Masu
    Eri Arikawa-Hirasawa
    Tadao Arinami
    Neuropsychopharmacology, 2010, 35 : 1155 - 1164
  • [28] Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia
    Sirota, P
    Mosheva, T
    Shabtay, H
    Giladi, N
    Korczyn, AD
    AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (02): : 287 - 289
  • [29] NEUROLEPTIC-INDUCED TARDIVE-DYSKINESIA AND PARKINSONISM - CHANGES DURING SEVERAL YEARS OF CONTINUING TREATMENT
    CASEY, DE
    POVLSEN, UJ
    MEIDAHL, B
    GERLACH, J
    PSYCHOPHARMACOLOGY BULLETIN, 1986, 22 (01) : 250 - 253
  • [30] CLINICAL AND INSTRUMENTAL ASSESSMENT OF NEUROLEPTIC-INDUCED PARKINSONISM IN PATIENTS WITH TARDIVE-DYSKINESIA
    CALIGIURI, MP
    LOHR, JB
    BRACHA, HS
    JESTE, DV
    BIOLOGICAL PSYCHIATRY, 1991, 29 (02) : 139 - 148
12345